Evidence map›Paper›PMID 31965432›Full record

Trial reportAIDS and behavior2020

A Randomized Controlled Trial of the Shikamana Intervention to Promote Antiretroviral Therapy Adherence Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kenya: Feasibility, Acceptability, Safety and Initial Effect Size.

Susan M Graham, Murugi Micheni, Oscar Chirro, Joseph Nzioka, Andrew M Secor, Peter M Mugo, Bernadette Kombo, Elise M van der Elst, Don Operario, K Rivet Amico and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
0.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Participatory development of theAdvances in global health · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Susan M GrahamDepartments of Medicine, Global Health, and Epidemiology, University of Washington, 325 Ninth Avenue, Box 359909, Seattle, WA, 98104, USA. grahamsm@uw.edu.ORCID http://orcid.org/0000-0001-7847-8686
Murugi MicheniClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Oscar ChirroClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Joseph NziokaClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Andrew M SecorDepartment of Global Health, University of Washington, Seattle, WA, USA.
Peter M MugoClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Bernadette KomboPartners for Health and Development in Africa, Nairobi, Kenya.
Elise M van der ElstClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Don OperarioDepartment of Behavioral and Social Sciences, Brown University, Providence, RI, USA.
K Rivet AmicoHealth Behavior and Health Education, University of Michigan, Ann Arbor, MI, USA.
Eduard J SandersClinical Research, Kenya Medical Research Institute - Wellcome Trust Programme, Kilifi, Kenya.
Jane M SimoniDepartments of Psychology; Global Health; and Gender, Women, and Sexuality Studies, University of Washington, Seattle, WA, USA.
Kenya Medical Research Institute · KEUniversity of Washington · USBrown University · USPartners for Health and Development in Africa · KEUniversity of Michigan · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESISR37HD007796 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI EMERSON, CHARLES P. · 2000 to 2010
$7.2M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESISR01HD007796 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI EMERSON, CHARLES P. · 1985 to 2014
$3.1M
Provider and Peer Support Intervention to Improve ART Adherence among Kenyan MenR34MH099946 · NIMH · UNIVERSITY OF WASHINGTON · PI GRAHAM, SUSAN MARIE · 2013 to 2015
$627k
Mentoring Diverse Scientists in Global HIV Research on Mental Health & AdherenceK24MH093243 · NIMH · UNIVERSITY OF WASHINGTON · PI SIMONI, JANE M. · 2011 to 2014
$590k
NIAID NIH HHS P30 AI027757NICHD NIH HHS R01 HD007796NICHD NIH HHS R37 HD007796NIH HHS K24 MH093243NIH HHS P30 AI027757NIH HHS R24 HD07796NIH HHS R34 MH099946NIMH NIH HHS K24 MH093243NIMH NIH HHS R25 MH067127NIMH NIH HHS R34 MH099946Wellcome TrustWellcome Trust #203077/Z/16/Z
6 · The paper itself

Abstract

Gay, bisexual, and other men who have sex with men (GBMSM) living with HIV in rights-constrained settings need support for antiretroviral therapy (ART) adherence due to barriers including stigma. The Shikamana intervention combined modified Next Step Counseling by providers with support from trained peers to improve adherence among GBMSM living with HIV in Kenya. A randomized controlled trial with 6-month follow-up was used to determine feasibility, acceptability, safety, and initial intervention effects. Generalized estimating equations examined differences in self-reported adherence and virologic suppression. Sixty men enrolled, with 27 randomly assigned to the intervention and 33 to standard care. Retention did not differ by arm, and no adverse events occurred. Feedback on feasibility and acceptability was positive based on exit interviews. After adjustment for baseline viral suppression and confounding, the intervention group had a sixfold increased odds of viral suppression during follow-up. A larger trial of a scaled-up intervention is needed.

Indexed as

Homosexuality, MaleSexual and Gender MinoritiesAdolescentAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveFeasibility StudiesFemaleHIV InfectionsHumansKenyaMaleMedication AdherenceMiddle AgedOutcome Assessment, Health CarePatient Acceptance of Health CareAnti-HIV AgentsAntiretroviral therapyCounselingHIVMedication adherencePeer group

Identifiers

PMID31965432
PMCPMC7319885
OpenAlexW3001704313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.